{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:30:50Z","timestamp":1790926250028,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81625007"],"award-info":[{"award-number":["81625007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600949"],"award-info":[{"award-number":["81600949"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91749206"],"award-info":[{"award-number":["91749206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00401-018-1891-2","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T01:40:20Z","timestamp":1533260420000},"page":"525-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Physiological clearance of tau in the periphery and its therapeutic potential for tauopathies"],"prefix":"10.1007","volume":"136","author":[{"given":"Jun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Sheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Le","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Qian","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin-Lu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Qing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Hua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Fang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-6112","authenticated-orcid":false,"given":"Yan-Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exger.2016.12.006","volume":"94","author":"M Barron","year":"2017","unstructured":"Barron M, Gartlon J, Dawson LA, Atkinson PJ, Pardon MC (2017) A state of delirium: deciphering the effect of inflammation on tau pathology in Alzheimer\u2019s disease. Exp Gerontol 94:103\u2013107. \n                    https:\/\/doi.org\/10.1016\/j.exger.2016.12.006","journal-title":"Exp Gerontol"},{"key":"1891_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nrd2959","volume":"8","author":"KR Brunden","year":"2009","unstructured":"Brunden KR, Trojanowski JQ, Lee VM (2009) Advances in tau-focused drug discovery for Alzheimer\u2019s disease and related tauopathies. Nat Rev Drug Discov 8:783\u2013793. \n                    https:\/\/doi.org\/10.1038\/nrd2959","journal-title":"Nat Rev Drug Discov"},{"key":"1891_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.204","author":"XL Bu","year":"2017","unstructured":"Bu XL, Xiang Y, Jin WS, Wang J, Shen LL, Huang ZL, Zhang K, Liu YH, Zeng F, Liu JH et al (2017) Blood-derived amyloid-beta protein induces Alzheimer\u2019s disease pathologies. Mol Psychiatry. \n                    https:\/\/doi.org\/10.1038\/mp.2017.204","journal-title":"Mol Psychiatry"},{"key":"1891_CR4","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","volume":"34","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Lasagna-Reeves CA, Gerson JE, Singh G, Estes DM, Barrett AD, Dineley KT, Jackson GR et al (2014) Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci 34:4260\u20134272. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3192-13.2014","journal-title":"J Neurosci"},{"key":"1891_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.108","author":"K Chiotis","year":"2017","unstructured":"Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G et al (2017) Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer\u2019s disease dementia. Mol Psychiatry. \n                    https:\/\/doi.org\/10.1038\/mp.2017.108","journal-title":"Mol Psychiatry"},{"key":"1891_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00401-013-1231-5","volume":"127","author":"F Clavaguera","year":"2014","unstructured":"Clavaguera F, Hench J, Lavenir I, Schweighauser G, Frank S, Goedert M, Tolnay M (2014) Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol 127:299\u2013301. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1231-5","journal-title":"Acta Neuropathol"},{"key":"1891_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0013-z","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. \n                    https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nat Rev Neurol"},{"key":"1891_CR8","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jalz.2016.06.001","volume":"12","author":"JL Dage","year":"2016","unstructured":"Dage JL, Wennberg AMV, Airey DC, Hagen CE, Knopman DS, Machulda MM, Roberts RO, Jack CR Jr, Petersen RC, Mielke MM (2016) Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 12:1226\u20131234. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2016.06.001","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1891_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-010-0786-7","volume":"121","author":"G Marco De","year":"2011","unstructured":"De Marco G, Lupino E, Calvo A, Moglia C, Buccinna B, Grifoni S, Ramondetti C, Lomartire A, Rinaudo MT, Piccinini M et al (2011) Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol 121:611\u2013622. \n                    https:\/\/doi.org\/10.1007\/s00401-010-0786-7","journal-title":"Acta Neuropathol"},{"key":"1891_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1460-9568.2008.06318.x","volume":"28","author":"N Deters","year":"2008","unstructured":"Deters N, Ittner LM, Gotz J (2008) Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Eur J Neurosci 28:137\u2013147. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06318.x","journal-title":"Eur J Neurosci"},{"key":"1891_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-008-0389-8","volume":"116","author":"P Foulds","year":"2008","unstructured":"Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, Snowden JS, Allsop D, Mann DM (2008) TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Acta Neuropathol 116:141\u2013146. \n                    https:\/\/doi.org\/10.1007\/s00401-008-0389-8","journal-title":"Acta Neuropathol"},{"key":"1891_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665\u2013704. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1707-9","journal-title":"Acta Neuropathol"},{"key":"1891_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12974-015-0443-0","volume":"12","author":"S Gyoneva","year":"2015","unstructured":"Gyoneva S, Kim D, Katsumoto A, Kokiko-Cochran ON, Lamb BT, Ransohoff RM (2015) Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury. J Neuroinflamm 12:228. \n                    https:\/\/doi.org\/10.1186\/s12974-015-0443-0","journal-title":"J Neuroinflamm"},{"key":"1891_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","volume":"24","author":"X Hu","year":"2006","unstructured":"Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT, Woodgett JR, Ivashkiv LB (2006) IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins. Immunity 24:563\u2013574. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2006.02.014","journal-title":"Immunity"},{"key":"1891_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy. J Neurosci 33:1024\u20131037. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2642-12.2013","journal-title":"J Neurosci"},{"key":"1891_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00401-015-1458-4","volume":"130","author":"M Iba","year":"2015","unstructured":"Iba M, McBride JD, Guo JL, Zhang B, Trojanowski JQ, Lee VM (2015) Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC\u2019s afferent and efferent connections. Acta Neuropathol 130:349\u2013362. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1458-4","journal-title":"Acta Neuropathol"},{"key":"1891_CR17","doi-asserted-by":"publisher","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","volume":"34","author":"JJ Iliff","year":"2014","unstructured":"Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L, Singh I, Deane R, Nedergaard M (2014) Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34:16180\u201316193. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3020-14.2014","journal-title":"J Neurosci"},{"key":"1891_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal K, Liu F, Gong CX (2016) Tau and neurodegenerative disease: the story so far. Nat Rev Neurol 12:15\u201327. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2015.225","journal-title":"Nat Rev Neurol"},{"key":"1891_CR19","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","volume":"173","author":"MC Janelsins","year":"2008","unstructured":"Janelsins MC, Mastrangelo MA, Park KM, Sudol KL, Narrow WC, Oddo S, LaFerla FM, Callahan LM, Federoff HJ, Bowers WJ (2008) Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Am J Pathol 173:1768\u20131782. \n                    https:\/\/doi.org\/10.2353\/ajpath.2008.080528","journal-title":"Am J Pathol"},{"key":"1891_CR20","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1038\/tp.2016.186","volume":"6","author":"SS Jiao","year":"2016","unstructured":"Jiao SS, Shen LL, Zhu C, Bu XL, Liu YH, Liu CH, Yao XQ, Zhang LL, Zhou HD, Walker DG et al (2016) Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer\u2019s disease. Transl Psychiatry 6:e907. \n                    https:\/\/doi.org\/10.1038\/tp.2016.186","journal-title":"Transl Psychiatry"},{"key":"1891_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-017-1721-y","volume":"134","author":"WS Jin","year":"2017","unstructured":"Jin WS, Shen LL, Bu XL, Zhang WW, Chen SH, Huang ZL, Xiong JX, Gao CY, Dong Z, He YN et al (2017) Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP\/PS1 mouse model. Acta Neuropathol 134:207\u2013220. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1721-y","journal-title":"Acta Neuropathol"},{"key":"1891_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","volume":"133","author":"KA Josephs","year":"2017","unstructured":"Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, Weigand SD, Boeve BF, Kantarci K, Petrucelli L et al (2017) Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol 133:705\u2013715. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1681-2","journal-title":"Acta Neuropathol"},{"key":"1891_CR23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jalz.2016.06.006","volume":"12","author":"MR Khanna","year":"2016","unstructured":"Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR (2016) Therapeutic strategies for the treatment of tauopathies: hopes and challenges. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 12:1051\u20131065. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2016.06.006","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1891_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12264-017-0174-6","volume":"33","author":"W Le","year":"2017","unstructured":"Le W, Dong J, Li S, Korczyn AD (2017) Can biomarkers help the early diagnosis of Parkinson\u2019s disease? Neurosci Bull 33:535\u2013542. \n                    https:\/\/doi.org\/10.1007\/s12264-017-0174-6","journal-title":"Neurosci Bull"},{"key":"1891_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-015-1507-z","volume":"131","author":"J Lewis","year":"2016","unstructured":"Lewis J, Dickson DW (2016) Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27\u201348. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1507-z","journal-title":"Acta Neuropathol"},{"key":"1891_CR26","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","volume":"23","author":"Y Li","year":"2003","unstructured":"Li Y, Liu L, Barger SW, Griffin WS (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23:1605\u20131611","journal-title":"J Neurosci"},{"key":"1891_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337\u2013341. \n                    https:\/\/doi.org\/10.1038\/nature14432","journal-title":"Nature"},{"key":"1891_CR28","doi-asserted-by":"publisher","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harbor Perspect Med 2:a006247. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a006247","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"1891_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","volume":"38","author":"ME Orr","year":"2017","unstructured":"Orr ME, Sullivan AC, Frost B (2017) A brief overview of tauopathy: causes, consequences, and therapeutic strategies. Trends Pharmacol Sci 38:637\u2013648. \n                    https:\/\/doi.org\/10.1016\/j.tips.2017.03.011","journal-title":"Trends Pharmacol Sci"},{"key":"1891_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ni.2043","volume":"12","author":"SH Park","year":"2011","unstructured":"Park SH, Park-Min KH, Chen J, Hu X, Ivashkiv LB (2011) Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat Immunol 12:607\u2013615. \n                    https:\/\/doi.org\/10.1038\/ni.2043","journal-title":"Nat Immunol"},{"key":"1891_CR31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-017-1705-y","volume":"133","author":"G Pascual","year":"2017","unstructured":"Pascual G, Wadia JS, Zhu X, Keogh E, Kukrer B, van Ameijde J, Inganas H, Siregar B, Perdok G, Diefenbach O et al (2017) Immunological memory to hyperphosphorylated tau in asymptomatic individuals. Acta Neuropathol 133:767\u2013783. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1705-y","journal-title":"Acta Neuropathol"},{"key":"1891_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.162","author":"JC Polanco","year":"2017","unstructured":"Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, Gotz J (2017) Amyloid-beta and tau complexity\u2014towards improved biomarkers and targeted therapies. Nat Rev Neurol. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.162","journal-title":"Nat Rev Neurol"},{"key":"1891_CR33","doi-asserted-by":"publisher","first-page":"20522","DOI":"10.1074\/jbc.M111.323279","volume":"287","author":"I Santa-Maria","year":"2012","unstructured":"Santa-Maria I, Varghese M, Ksiezak-Reding H, Dzhun A, Wang J, Pasinetti GM (2012) Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes. J Biol Chem 287:20522\u201320533. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.323279","journal-title":"J Biol Chem"},{"key":"1891_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0071-z","author":"LL Shen","year":"2018","unstructured":"Shen LL, Manucat-Tan NB, Gao SH, Li WW, Zeng F, Zhu C, Wang J, Bu XL, Liu YH, Gao CY et al (2018) The ProNGF\/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau. Mol Psychiatry. \n                    https:\/\/doi.org\/10.1038\/s41380-018-0071-z","journal-title":"Mol Psychiatry"},{"key":"1891_CR35","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","volume":"12","author":"M Shi","year":"2016","unstructured":"Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P et al (2016) CNS tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 12:1125\u20131131. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2016.04.003","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1891_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C et al (2014) Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol 128:639\u2013650. \n                    https:\/\/doi.org\/10.1007\/s00401-014-1314-y","journal-title":"Acta Neuropathol"},{"key":"1891_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al (2015) Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 11:457\u2013470. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"key":"1891_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.201407065","volume":"209","author":"KA Vossel","year":"2015","unstructured":"Vossel KA, Xu JC, Fomenko V, Miyamoto T, Suberbielle E, Knox JA, Ho K, Kim DH, Yu GQ, Mucke L (2015) Tau reduction prevents Abeta-induced axonal transport deficits by blocking activation of GSK3beta. J Cell Biol 209:419\u2013433. \n                    https:\/\/doi.org\/10.1083\/jcb.201407065","journal-title":"J Cell Biol"},{"key":"1891_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang J, Gu BJ, Masters CL, Wang YJ (2017) A systemic view of Alzheimer disease\u2014insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol 13:612\u2013623. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.111","journal-title":"Nat Rev Neurol"},{"key":"1891_CR40","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss A, Trager U, Wild EJ, Grueninger S, Farmer R, Landles C, Scahill RI, Lahiri N, Haider S, Macdonald D et al (2012) Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. J Clin Investig 122:3731\u20133736. \n                    https:\/\/doi.org\/10.1172\/JCI64565","journal-title":"J Clin Investig"},{"key":"1891_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Bu XL, Liu YH, Zhu C, Shen LL, Jiao SS, Zhu XY, Giunta B, Tan J, Song WH et al (2015) Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 130:487\u2013499. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1477-1","journal-title":"Acta Neuropathol"},{"key":"1891_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-018-9895-1","author":"SH Xin","year":"2018","unstructured":"Xin SH, Tan L, Cao X, Yu JT, Tan L (2018) Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy. Neurotox Res. \n                    https:\/\/doi.org\/10.1007\/s12640-018-9895-1","journal-title":"Neurotox Res"},{"key":"1891_CR43","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, Cirrito JR, Patel TK, Hochgrafe K, Mandelkow EM et al (2014) Neuronal activity regulates extracellular tau in vivo. J Exp Med 211:387\u2013393. \n                    https:\/\/doi.org\/10.1084\/jem.20131685","journal-title":"J Exp Med"},{"key":"1891_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K, Kfoury N, Jiang H, Mahan Thomas E, Ma S, Maloney Susan E, Wozniak David F, Diamond Marc I, Holtzman David M (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80:402\u2013414. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2013.07.046","journal-title":"Neuron"},{"key":"1891_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2029","author":"K Yanamandra","year":"2017","unstructured":"Yanamandra K, Patel TK, Jiang H, Schindler S, Ulrich JD, Boxer AL, Miller BL, Kerwin DR, Gallardo G, Stewart F et al (2017) Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy. Sci Transl Med. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aal2029","journal-title":"Sci Transl Med"},{"key":"1891_CR46","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/mp.2015.49","volume":"20","author":"XQ Yao","year":"2015","unstructured":"Yao XQ, Jiao SS, Saadipour K, Zeng F, Wang QH, Zhu C, Shen LL, Zeng GH, Liang CR, Wang J et al (2015) p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer\u2019s disease. Mol Psychiatry 20:1301\u20131310. \n                    https:\/\/doi.org\/10.1038\/mp.2015.49","journal-title":"Mol Psychiatry"},{"key":"1891_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3892\/or.2017.6134","volume":"39","author":"H Zou","year":"2018","unstructured":"Zou H, Wen C, Peng Z, Shao Y, Hu L, Li S, Li C, Zhou HH (2018) P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas. Oncol Rep 39:501\u2013510. \n                    https:\/\/doi.org\/10.3892\/or.2017.6134","journal-title":"Oncol Rep"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-018-1891-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1891-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T14:43:41Z","timestamp":1569163421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-018-1891-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1007\/s00401-018-1891-2","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}